The goal of this research was detection of the drug-resistance level of Mycobacterium tuberculosis infection in the Odesa region of Southwest Ukraine, investigation of the level of mutation in katG and rpoB genes for M. tuberculosis with polymerase chain reaction (PCR), and spread of these mutations in different groups of patients with tuberculosis. An extremely high level of primary and acquired resistance of M. tuberculosis to first-line antituberculosis drugs has been found in the Southwest region of Ukraine. The PCR method has proved to have high sensitivity in the detection of mutations in katG and rpoB genes. The data showed significant spreading of M. tuberculosis strains with mutations in katG and rpoB genes in penitentiaries and an increased level of these mutations during tuberculosis treatment. The presence of mutations in rpoB and katG genes was associated with a more severe course of tuberculosis, increased risk of treatment default, persistence of positive smears on microscopy at discharge, and poor closing of tuberculous cavities. Extremely high level of mutations in the rpoB and katG genes of M. tuberculosis was observed in Beijing family strains. Our findings support the capability of the PCR method to detect M. tuberculosis that is resistant to drugs such as isoniazid and rifampicin.
Introduction
The leading reason for the high rate of tuberculosis (TB) spreading across many East European countries is an unacceptably high level of drug-resistant Mycobacterim tuberculosis infection [1] . During 2000 During -2004 , the level of multidrug-resistant M. tuberculosis infection increased worldwide from 29% to 39% [2] . Because the routine culture method of drug-resistance detection takes 1-2 months, the molecular methods of detection appear quite promising. During last two decades, certain mutations in M. tuberculosis genotype that cause drug resistance have been revealed. In the scientific literature, molecular methods are described for detection of mutations in the rpoB and katG genes that lead, respectively, to rifampicin and isoniazid resistance [3, 4] . The main advantages of the molecular methods are their high sensitivity and rapidity in obtaining results; however, these methods are not used routinely in Ukraine.
Aim of present research
Our aims were the detection of the drug-resistance level of M. tuberculosis in the Odesa region of Southwest Ukraine, investigation of the level of mutations in katG and rpoB genes of M. tuberculosis with use of polymerase chain reaction (PCR), and analysis of the spread of mutations in different groups of patients infected by M. tuberculosis.
Material and Methods
Primary and acquired resistance of M. tuberculosis to first-line antituberculosis drugs was studied according to results obtained in 2006 by the bacteriological laboratory of Odesa oblast (district) clinical tuberculosis hospital. The total included 224 cultures of M. tuberculosis; 107 isolates of M. tuberculosis obtained from patients who were treated in that hospital were studied with multiplex allele-specific PCR (MAS-PCR) [3, 4] . The DNA extraction was performed in the same laboratory. The "crosssectional" method of culture selection was applied [5] , and the research was approved by the bioethics commission of Odesa State Medical University.
Detection of the mutation that leads to isoniazid resistance was performed with MAS-PCR with modification [3, 6] . The method targets mutation in codon 315 katG gene with three primers. MAS-PCR was also used in the study of the mutation responsible for rifampicin resistance [4] . The method revealed mutations at codons 516, 526, 531 in the rpoB gene with use of three inner direct primers and one reverse primer.
For recognition, either a strain of M. tuberculosis belongs to the Beijing family that is characterized by high resistance, or not the PCR was used as well [7] . The method is based on demonstrating insertion fragment IS6110 in intergenes locus dnaA-dnaN by two primers. Statistical analysis of results was done with Microsoft Excel involving χ-square criteria.
Results
Out of 224 cultures, 54 (24.1%) were obtained from patients with a newly diagnosed case of TB. The level of primary resistance to the first-line antituberculosis drugs was the lowest for pyrazinamide (22.2%) and the highest for streptomycin and rifampicin (59.3% and 61.1%, respectively) ( Figure 1 ). Approximately 22.2% of the cultures showed primary multidrug resistance (combined resistance to isoniazid and rifampicin); 5.6% of the cultures were resistant to all first-line antituberculosis drugs. Only 9.3% of the cultures showed susceptibility to all first-line drugs.
The level of acquired resistance was the lowest for pyrazinamide (42.9%) and the highest for rifampicin (80.6%) (Figure 1 ). Out of 170 cultures studied for acquired (secondary) resistance, only 5.9% remained susceptible to all first-line drugs, whereas 31.2% of the cultures were resistant to all first-line drugs. The level of acquired multidrug resistance was approximately 64.1%.
Acquired multidrug resistance and resistance to all first-line drugs were 2.9 and 5.6 times higher than primary resistance; resistance to isoniazid, rifampicin, and pyrazinamide was increased 2, 1.3, and 1.9 times, respectively ( Figure 1 ).
Approximately 54.2% of isolates carried a mutation at codon 315 in the katG gene ( Figure 2 ). Among all isolates that carried the mutation in the katG gene, 84.5% were isoniazid-resistant according to the culture method. Out of all isoniazid-resistant strains, approximately 87.5% had the mutation in the katG gene. Thus, the specificity of this method was 84.5%, and the sensitivity was 87.5%.
The level of the mutations in the rpoB gene was 44.9% ( Figure 2 ). Out of all the mutated strains, 4.8% had a mutation at codon 516 in the rpoB gene; 14.3% had a mutation at codon 526, and in 80.9% a mutation at codon 531. Out of all isolates that carried any mutation at codons 516/526/531 in the rpoB gene, 93.8% were rifampicin-resistant according to the culture method. Of rifampicin-resistant strains, only 49.5% carried any mutation at codons 516/526/531 in the rpoB gene. So, the specificity of this method for rifampicin-resistance detection was 93.8%, and the sensitivity 49.5%.
In general, 43.0% of M. tuberculosis strains belong to the Beijing family. In newly diagnosed cases of TB, primary mutations in the katG and rpoB genes were observed 3 and 2.8 times, respectively, more frequently in Beijing strains than in non-Beijing strains (Table 1) . Simultaneous mutations in katG and rpoB genes were found to be more frequent in Beijing strains than in nonBeijing strains, both in newly diagnosed cases of TB and in cases that had been treated for at least 4 weeks (termed an acquired mutation).
We noticed some peculiarities regarding the spread of mutations in the katG and rpoB genes in different patients. Strains of M. tuberculosis with a mutation in the katG gene in 3 times more frequently were obtained from drug-abusers than from non-drug abusers; also, mutated strains in 1.7 times more frequently were observed in patients with prison history and in patients who had contact with patients with TB before the disease started.
The patients infected by M. tuberculosis with a mutation in the rpoB gene had a prison history 1.8 times more often and had previous anti-tuberculosis treatment 1.6 times more frequently than patients with wild-type (non-mutated) strains .
In the majority of cases, patients who carried M. tuberculosis without mutation in katG gene had a new case of TB (85.7%) and rarely had a chronic case (10.2%). In patients with mutated strains, new cases of tuberculosis occurred 1.5 times less often than in the group with wild-type strains, whereas chronic tuberculosis developed 3 times more often in patients with mutated strains than it did in the wild-type group (Figure 3) . 
*-P<0.05 relative to patients who carried mutated strains;
At discharge from the hospital, the patients with a mutation in the katG gene of M. tuberculosis exhibited resolution of TB-infiltration in lungs and closing of tuberculous cavities in the lungs 3.3 times less often than patients with wild-type strains, whereas on microscopical examination the smears of those with the mutation remained positive 3 times more often than did those of patients with wild-type strains.
The patients who carried M. tuberculosis with a mutation in the rpoB gene had 1.5 times fewer new cases than did the patients with wild-type strains, and patients with the rpoB mutation had chronic TB 2.6 times more frequently than those with wild-type strains (Р<0.05). At discharge, the smears of patients with wild-type isolates were 1.9 times more frequently negative at microscopy than those of patients with a mutation in the rpoB gene of M. tuberculosis (Р<0.05).
Among the reasons for discharge of the patients who carried M. tuberculosis with mutations of the katG gene, default (abortion of treatment) appeared 2 times more often than in patients who were carriers of wildtype strains, whereas continuation of course (transfer from hospital for out-patient treatment) was 2 times less common (Figure 4 ). In the patients who carried M. tuberculosis with mutations of the katG gene lethal outcome was observed 6 times more frequently than in the patients with non-mutated strains. The patients who carried M. tuberculosis with a mutation in the rpoB gene were transferred for out-patient treatment 1.8 times less often than the patients who carried wild-type strains, and 1.9 times more frequently had aborted antituberculosis treatment than did the patients who carried wild-type strains.
Discussion
On the basis of previous data concerning drug-resistant M. tuberculosis infection in the Odesa region, we concluded that there was a continuous increase in the Odesa region during 2000-2006 [8] . For instance, the spread of isoniazid-and rifampicin-resistance increased 2.7-4.1 times; multiresistance increased 5.5 times ( Figure 5) .
It is known that in Western Europe the maximum allowed level of primary multidrug resistance is approximately 3% [9] ; however, the data we obtained revealed that in Odesa region it is almost 7 times higher. According to published data, the level of primary multidrug-resistant TB in 2002-2005 in different regions of Ukraine varied from 4.9% to 23.1%; the level of acquired multiresistance was 45.1-59.0% [2, 10] . Spreading of multidrug-resistant tuberculosis has been witnessed in the Odesa district and Ukraine, which is dangerous because such cases require more complex therapy and remain a constant source of drug-resistant tuberculosis.
The specificity of MAS-PCR for detection of isoniazid resistance was 84.5%, with a sensitivity of 87.5%. At the same time, the specificity of rifampicin-resistance detection was 93.8%, with a sensitivity of 49.5%. It is probable, although not included in our research, that mutations in the inhA gene of M. tuberculosis could contribute to isonazid resistance or that mutations at other than codons 516, 526, and 531 in the rpoB gene could cause rifampicin resistance. In comparison to the years 2003-2004 in the Odesa district, the level of mutation at codon 315 of the katG gene remained almost unchanged, while mutations in the rpoB gene increased approximately 1.5 times [11] . * * * 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
*-P<0,05 compared to the patients-carriers of M.tuberculosis with mutation in katG gene
In general, 43.0% of M. tuberculosis strains belonged to the Beijing family, which showed a slight increase over the data from 2003 (39.6%) [12] . In the Beijing family strains, mutations at codon 315 in the katG gene and/ or at codon 516/526/531 in the rpoB gene were found more often than in other strains, and that observation has been corroborated by other research worldwide [2] . Thus, the majority of wild-type strains belong to the nonBeijing group; however, the majority of mutated strains are from the Beijing family.
Mutations in the rpоB and katG genes analysed in our study were more often obtained from patients with chronic (i.e., a repeated course of) tuberculosis. This fact has proved the appearance of the mutations during antituberculosis treatment. In addition, mutations in the rpоB and katG genes were observed more frequently in patients with a prison history, and that finding is supported by the research of other authors [1, 13] . At the same time, spread of Beijing family strains significantly increases the risk of contamination by M. tuberculosis strains with a high level of mutation in the rpоB and katG genes that leads to rifampicin and isoniazid resistance before initiation of chemotherapy. Thus, we have evidence of both the continued spread of mutated strains and the development of drug resistance during tuberculosis treatment.
According to the literature, infection with HIV and alcohol abuse are risk factors for the development of TB and the appearance of drug resistance in M. tuberculosis infection [14, 15] , but our research failed to support an association between HIV infection and alcoholism, on one hand, and the development of mutations in the rpоB and katG genes in patients with TB, on the other hand.
Among the reasons for discharge of the patients who carried M. tuberculosis with mutations in both the katG and rpoB genes, the main one was default (abortion of treatment), whereas for carriers of wildtype, it was completion of in-patient treatment and continuation of therapy under out-patient conditions. According to modern DOTS (Directly Observed Therapy, Short-course) therapy of tuberculosis, the complete fulfillment of the chemotherapy is extremely important for successful treatment. The mutation in the katG gene was associated with a much higher mortality rate during 2006 than were the wild-type strains. Thus, the absence of mutations in the rpоB and katG genes is an important prognostic criterion for the success of TB treatment. 
